The BRIC CGM market witnessed strong growth in recent decades and is further expected to grow primarily due to the increasing adaptation of continuous glucose monitoring devices in China and India. This rising diabetic population in Brazil, Russia, India, and China and increasing the adoption of CGM devices and Continuous Positive Cost-Effective Analysis by BRIC Countries will propel the growth of the BRIC CGM market. China has the largest market share in 2019; while, India is foreseen to witness a significant market share during the forecast period. According to Renub Research analysis, the BRIC CGM Market will reach US$ 868 Million by the end of the year 2025.

Follow the Link for Report Customization: https://www.renub.com/bric-cgm-market-p.php

The BRIC CGM market is driven mainly by the increasing numbers of people with diabetes across BRIC countries, growing diabetes research, and increasing international research collaborations. The Continuous Positive Cost-Effective Analysis by BRICS Countries and rapid urbanization and CGM Technology Convenient for both Patients & Physicians are further expected to contribute to the growth of this CGM market. However, Controversy regarding Clinical Benefits and the high cost of diabetes care devices are the remonstrance growth of this market.


In the year Feb 2019, Senseonics made a distribution agreement with Roche Diabetes Care for two years, giving exclusive rights to the Big Biotech for selling implantable glucose monitoring systems in Brazil, Russia, India, and China. The continuous glucose monitoring (CGM) devices market in BRIC countries are set to thrive regardless of the major upheaval caused by the COVID-19 pandemic. The surging demand for CGM in BRIC countries are primarily driven by a growing awareness of the devices and companies' quick responses to the COVID-19 epidemic.


Renub Research latest study “BRIC CGM Market, Users, Reimbursement Policy, CGM Components (Glucose Sensor, Transmitter) Market, Diabetes (Type1 & 2) Population, & Forecast” provides a detailed and comprehensive insight of the BRIC CGM Market.

• CGM Market
• CGM Users
• CGM Reimbursements Policy


Request a free Sample copy of the report: https://www.renub.com/request-sample-page.php?gturl=bric-cgm-market-p.php


Scope of the Report

• CGM Market & Forecast: In this report, we have fragmented the CGM market into two parts; CGM transmitter market and CGM Sensor Market. We have cover 4 countries along with growth factors.

• CGM Users & Forecast: We have computed CGM user of top 4 countries. Historical data is computed from 2011-2019, and forecast data would be shown from 2020-2025.

• Reimbursement Policy: This report provides a changing picture of Reimbursement Policy on CGM (Continuous Glucose Monitoring) BRIC and country wise. Reimbursement model of BRIC that will give the overall situation of CGM acceptance across private and public hospitals and insurer.

• Diabetes Population: Report covers population & forecast of 4 (Type 1 and Type 2 diabetes)

• Growth Factors for CGM: This report studies the key factor that would help the CGM industry to outperform.

• Challenges for CGM: This industry shows the problems being faced by the CGM technology and industry.


Countries Covered

1.    Brazil
2.    Russia
3.    India
4.    China


About Company:

Renub Research is a Market Research and Consulting Company. We have more than 10 years of experience especially in international Business-to-Business Researches, Surveys and Consulting. We provide wide range of business research solutions that helps companies in making better business decisions. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses. Our wide clientele comprises of major players in Life Sciences, Information Technology, Telecom, Financial Services (Banking, Insurance), Energy, Retail, Manufacturing, Automotive, and Social sector. Our clients rely on our market analysis and data to make informed knowledgeable decisions. We are regarded as one of the best providers of knowledge. Our pertinent analysis helps consultants, bankers and executives to make informed and correct decisions.


Contact Us:
Renub Research
Phone No: +1 678-302-0700 (USA) | +91-120-421-9822 (IND)
Email: [email protected]
Web: https://www.renub.com
Follow on Linkedin: https://www.linkedin.com/company/renub-research